GP-Act III Acquisition Corp. $GPAT Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS decreased its stake in shares of GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report) by 86.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,900 shares of the company’s stock after selling 358,364 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in GP-Act III Acquisition were worth $584,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of GPAT. Westchester Capital Management LLC boosted its stake in shares of GP-Act III Acquisition by 22.5% in the 4th quarter. Westchester Capital Management LLC now owns 1,360,852 shares of the company’s stock valued at $14,561,000 after buying an additional 250,000 shares during the period. TENOR CAPITAL MANAGEMENT Co. L.P. acquired a new stake in GP-Act III Acquisition in the second quarter valued at approximately $7,800,000. L1 Global Manager Pty Ltd acquired a new stake in GP-Act III Acquisition in the fourth quarter valued at approximately $6,067,000. Meteora Capital LLC lifted its stake in GP-Act III Acquisition by 62.8% in the fourth quarter. Meteora Capital LLC now owns 408,719 shares of the company’s stock worth $4,369,000 after acquiring an additional 157,689 shares during the last quarter. Finally, Berkley W R Corp lifted its stake in GP-Act III Acquisition by 4.8% in the fourth quarter. Berkley W R Corp now owns 312,290 shares of the company’s stock worth $3,338,000 after acquiring an additional 14,298 shares during the last quarter.

GP-Act III Acquisition Stock Performance

NASDAQ GPAT opened at $11.12 on Friday. The company has a fifty day moving average of $10.94 and a two-hundred day moving average of $10.84. GP-Act III Acquisition Corp. has a 1 year low of $10.50 and a 1 year high of $12.00.

GP-Act III Acquisition (NASDAQ:GPATGet Free Report) last posted its earnings results on Thursday, May 14th. The company reported $0.06 EPS for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Tuesday, April 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, GP-Act III Acquisition has an average rating of “Sell”.

Check Out Our Latest Analysis on GP-Act III Acquisition

GP-Act III Acquisition Company Profile

(Free Report)

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.

Read More

Want to see what other hedge funds are holding GPAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report).

Institutional Ownership by Quarter for GP-Act III Acquisition (NASDAQ:GPAT)

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.